12:00 AM
 | 
Sep 02, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Piqur preclinical data

Piqur said PQR-309 led to anti-proliferative activity in vitro and antitumor efficacy in vivo, but could not be...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >